Quest wraps up $300M unit sale; Medical device alarms could distract docs, harm patients;

 @FierceMedDev: Report: Device tax is hard to decipher and kills jobs. More | Follow @FierceMedDev

 @MarkHFierce: Med device VC continues to be steady for late stage companies. iRhythm pulled in a $16M Series D. Release | Follow @MarkHFierce

 @DamianFierce: St. Jude won EU approval to treat dystonia with its deep-brain simulators. News | Follow @DamianFierce

> Quest Diagnostics ($DGX) has closed its $300 million sale of the HemoCue business to Danaher's ($DHR) Radiometer Medical unit. News

> Hospital workers are so desensitized by constantly beeping alarms from devices that monitor critically ill patients that they often ignore the noise and some patients die as a result. Story

> Insight Product Development in Chicago is launching Insight Labs, an accelerator program for budding medical device companies. Story

> Devicemaker Andain has completed all the tests required to secure FDA clearance for its miniature disposable insulin pump. More

> Baylor Health Care System in Dallas, Dignity Health in San Francisco and insurance giant United Healthcare formed a group that monitors effectiveness of devices including hip implants, heart valves and stents. Story

> Advanced Animal Diagnostics closed a $6 million Series B financing tranche from Intersouth Partners, Novartis Venture Funds and private investors. Release

> The Twin Cities remains a top-10 hub for med tech companies, according to a new report. Article

Biotech News

 @FierceBiotech: Trending: Groton throws up a new hurdle to Pfizer's R&D demolition plan. Story | Follow @FierceBiotech

 @JohnCFierce: Fun list from Evaluate on the top 10 blockbuster busts in biopharma. List | Follow @JohnCFierce.

 @RyanMFierce: Started my day 2 here at BioIT13 with a story about Novartis' big decision on whether to buy Proteon in $550M deal. News | Follow @RyanMFierce

> VistaGen raises $36M for stem cell tech. More

> Amid cheers and jeers, GlaxoSmithKline reveals Duchenne drug hit primary PhII goal. Article

> FDA stokes blockbuster hopes with 'breakthrough' brand for Pfizer cancer drug. News

Pharma News

 @FiercePharma: Trending yesterday: U.S. adults still skipping pills to save money, CDC finds. Article | Follow @FiercePharma

 @EricPFierce: Drugmakers with plants in EU still sweating whether China, India will meet deadline for new API regulations. Report | Follow @EricPFierce

> Lilly settles long-running lawsuit tying Cymbalta to teen's suicide. Story

> Merck kept mum on Fosamax's fracture risks, trial lawyer says. Report

Drug Delivery News

 @MichaelGFierce: From SpringLeaf's ashes, scPharma continues with minipump delivery. Article | Follow @MichaelGFierce

> TissueGen launches Elute drug-delivering fiber. News

> 3-D printer makes synthetic tissue for drug delivery. Report

> Self-assembling cancer drugs deliver themselves. Item

> Ambrx's cancer antibody delivery tech wins Astellas partnership. More

> Nano-delivered cell gatekeepers can improve drug performance, study finds. Story

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.